Judge Sanctions Roxane In Asacol Patent Suit
A federal judge has ruled that Roxane Laboratories Inc. must pay some of the expert and attorneys' fees for the plaintiffs in a patent dispute over inflammatory bowel drug Asacol as...To view the full article, register now.
Already a subscriber? Click here to view full article